CDEK
← All trials

NCT04208529

Phase 3Interventional

Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jan 20, 2021
Primary completion
Sep 30, 2039
Completion date
Sep 30, 2039
First posted
Dec 23, 2019
Last posted
Sep 19, 2024
Enrollment
160
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.